In the last many years, the amount of patients referred for allogeneic hematopoietic cell transplantation has dropped drastically,133 though the procedure should be proposed to young/suit patients in whom BCR/BCL2 inhibitor therapy fails, particularly in All those with TP53Deep, qualified following-technology sequencing has disclosed that subclonal